MedTrace Logo

VR Training for Nurses' Delirium Management

NCT06880263 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2025-06-03

No results posted yet for this study

Summary

Background:

Delirium is an acute mental status change characterized by confusion, fluctuating symptoms, and inattention. It affects 11%-40% of hospitalized elderly patients and over 80% of mechanically ventilated ICU patients. Early detection and intervention are crucial in preventing adverse outcomes. The Confusion Assessment Method for the ICU (CAM-ICU) has been widely adopted in Taiwan for delirium screening. However, nurses' knowledge and skills in delirium assessment remain insufficient.

Objective:

This study aims to evaluate the effectiveness of a spherical video-based virtual reality (SVVR) training system in improving nurses' delirium assessment and management skills.

Methods:

A parallel-group randomized controlled trial will be conducted. Participants (nurses aged 20-65) will be recruited via social media and screened for eligibility. They will be randomly assigned to:

Intervention group: SVVR-based delirium training using a head-mounted display. Control group: Standard video-based training via YouTube. Pre- and post-intervention assessments will measure delirium knowledge, attitudes, assessment skills, learning motivation, and technology acceptance. Quantitative data will be analyzed using SPSS (Version 25) with t-tests, ANOVA, and chi-square tests. Qualitative data will be analyzed using thematic analysis.

Expected Outcome:

This study will determine whether immersive VR training enhances nurses' delirium management skills more effectively than conventional video training.

Conditions

  • ICU Nurses, Delirium, Virtual Reality

Interventions

DEVICE

use 360 degree VR training

Participants will use Virtual Reality (VR) training

Sponsors & Collaborators

  • Tri-Service General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-17
Primary Completion
2025-05-21
Completion
2025-07-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06880263 on ClinicalTrials.gov